Trinity Biotech plc TRIB
5.83 USD -0.18 (-3.08%)
Regular-session close
5.61 -0.21 -3.69%
After hours · Nov 18, 4:00 PM ET
5.68 Day range 5.98
5.00 52-week range 52.50
- YTD
- -75.42%
- 1 year
- -76.32%
News
defenseworld.net Head-To-Head Survey: Trinity Biotech (NASDAQ:TRIB) vs. OrthoPediatrics (NASDAQ:KIDS) OrthoPediatrics (NASDAQ: KIDS - Get Free Report) and Trinity Biotech (NASDAQ: TRIB - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast…
globenewswire.com Trinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure Trinovium to supply RTI with advanced fluids and analytical systems for deployment in a U.S. commercial pilot focused on AI and high-performance computing data center infrastructure Data center power…
globenewswire.com Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update - Continued execution of transformation strategy drives commercial, manufacturing and pipeline progress - PrePsia™ patent portfolio expands to nine granted U.S. and European patents - Company issues…
globenewswire.com Trinity Biotech's Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure - Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular…
globenewswire.com Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement – Perceptive Advisors provides approximately $7.0 million of additional investment to further support strategic growth initiatives including CGM+, Trinovium and the Company's business transformation…
globenewswire.com Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology - Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to…
globenewswire.com Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change DUBLIN, July 22, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) representing…
globenewswire.com New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring - Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech's CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows…
globenewswire.com Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling - Milestone an important step in launching Trinovium within the global AI data center ecosystem - Data center liquid cooling market projected to expand from $4 billion in 2026 to $27 billion by 2033…
globenewswire.com Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville DUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions…
globenewswire.com Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market - New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and…
globenewswire.com Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results – Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets
globenewswire.com Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations - Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive…
defenseworld.net Trinity Biotech (TRIB) to Release Earnings on Wednesday Trinity Biotech (NASDAQ: TRIB - Get Free Report) is expected to release its Q4 2025 resultson Wednesday, April 8th. Analysts expect Trinity Biotech to post earnings of ($0.32) per share and revenue…
globenewswire.com Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global diagnostics company, today announced successful results from a clinical study of a new, enhanced…
defenseworld.net CompuMed (OTCMKTS:CMPD) & Trinity Biotech (NASDAQ:TRIB) Head-To-Head Review Trinity Biotech (NASDAQ: TRIB - Get Free Report) and CompuMed (OTCMKTS:CMPD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on…
globenewswire.com Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,…
globenewswire.com Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March 12, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech…
globenewswire.com Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program DUBLIN and WILSONVILLE, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management…
globenewswire.com Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform - Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics…
